NCT01662960

Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke

Completed NA Results posted Last updated 30 June 2020

What this trial tests

NA trial testing Mirror therapy in Hemiparesis in 72 participants. Completed in 27 February 2017.

Timeline

7 September 2012

Primary endpoint
27 February 2017

27 February 2017

Quick facts

Lead sponsor	Albert Einstein Healthcare Network
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	72
Start date	7 September 2012
Primary completion	27 February 2017
Estimated completion	27 February 2017
Sites	1 location across United States

Drugs / interventions tested

• Mirror therapy
• Divider therapy

Conditions studied

• Hemiparesis — all drugs for Hemiparesis →
• Stroke — all drugs for Stroke →

Sponsor

Albert Einstein Healthcare Network

Who can join

Adults 21 to 85, any sex, with Hemiparesis or Stroke. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Upper Extremity Fugl-Meyer Primary · Immediately after 1 month of treatment

This test measures impairment-level ability to move the arm and hand. Scores range from 0 to 66, with higher scores indicating greater ability to move the arm and hand.

Group	Value	95% CI
Mirror Therapy: High Functioning	43.8	± 9.4
Mirror Therapy: Low Functioning	21.4	± 5.7
Divider Therapy: High Functioning	42.8	± 8.7
Divider Therapy: Low Functioning	21.5	± 6.3

Action Research Arm Test Primary · 1 month

The test measures the ability to complete simulated everyday tasks with the arm. Scores range from 0 to 54, with higher scores indicating better performance.

Group	Value	95% CI
Mirror Therapy: High Functioning	39.9	± 11.8
Mirror Therapy: Low Functioning	7.1	± 5.0
Divider Therapy: High Functioning	39.1	± 13.6
Divider Therapy: Low Functioning	7.7	± 5.6

Rivermead Assessment of Somatosensory Performance Primary · 1 month

This test measures the integrity of sensory perception of the arm. The score is the proportion of items answered correctly, and ranges from 0 to 1 with higher scores indicating better performance.

Group	Value	95% CI
Mirror Therapy: High Functioning	0.76	± 0.18
Mirror Therapy: Low Functioning	0.52	± 0.19
Divider Therapy: High Functioning	0.79	± 0.18
Divider Therapy: Low Functioning	0.60	± 0.20

Stroke Impact Scale Secondary · 1 month

This test measures the self-reported ability to complete everyday tasks with the arm. Total scores for all items are reported. The scale ranged from 0 to 300, with higher scores indicating higher self-reported ability.

Group	Value	95% CI
Mirror Therapy: High Functioning	221.0	± 32.5
Mirror Therapy: Low Functioning	231.6	± 43.7
Divider Therapy: High Functioning	237.8	± 25.7
Divider Therapy: Low Functioning	217.0	± 26.7

Wolf Motor Function Test Secondary · 1 months

The test measures the ability to completed simulated everyday tasks with the arm. The scale ranged from 0 to 75, with higher scores indicating better performance.

Group	Value	95% CI
Mirror Therapy: High Functioning	50.0	± 10.0
Mirror Therapy: Low Functioning	22.3	± 6.0
Divider Therapy: High Functioning	50.4	± 13.8
Divider Therapy: Low Functioning	24.7	± 6.7

Sponsor's own description

The purpose of the study is to determine whether an existing treatment for problems that participants have with making movements after a stroke can be performed at home.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.